MedTrace Logo

Haemodialysis Alters Hypercoagulability of Blood in Dialysis Patients

NCT07098676 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2025-08-01

No results posted yet for this study

Summary

Primary Objective:

To develop a thrombotic event risk assessment model integrating serum biomarkers (TM, TAT, t-PAIC, PIC) with clinical data, systematically compare its predictive performance across healthy populations, vascular surgery patients with acute thrombosis, and dialysis patients, and evaluate its predictive advantages over the Padua Prediction Score and D-dimer.

Secondary Objective:

To investigate the expression profiles of these four thrombotic biomarkers in different populations and their associations with thrombotic event types and clinical contexts (e.g., duration of dialysis, anticoagulation regimens), identifying independent risk factors and underlying mechanisms to provide a scientific foundation for stratified thrombotic risk management and personalized intervention strategies.

Conditions

  • Healthy Individuals (Controls)
  • Vascular Surgery Patients With Acute Thrombosis
  • Dialysis Patients

Sponsors & Collaborators

  • Ai Peng

    lead OTHER

Principal Investigators

  • Changbin Li · Shanghai 10th People's Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-20
Primary Completion
2025-05-30
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07098676 on ClinicalTrials.gov